Myonal



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 9.5%
Hypertension 8.1%
Anxiety 7.6%
Drug Use For Unknown Indication 7.6%
Epilepsy 7.6%
Parkinson's Disease 7.6%
Back Pain 6.2%
Muscle Tightness 5.2%
Insomnia 4.8%
Periarthritis 4.8%
Rhinitis 4.3%
Bronchitis 3.3%
Diabetes Mellitus 3.3%
Cerebral Infarction 2.9%
Constipation 2.9%
Glaucoma 2.9%
Hypercholesterolaemia 2.9%
Muscle Spasms 2.9%
Osteoporosis 2.9%
Prophylaxis Against Gastrointestinal Ulcer 2.9%
Hypoglycaemia 14.6%
Stevens-johnson Syndrome 14.6%
Dermatitis Exfoliative 6.3%
Toxic Epidermal Necrolysis 6.3%
Abdominal Pain Upper 4.2%
Anaphylactic Shock 4.2%
Drug Eruption 4.2%
Gastric Cancer 4.2%
Idiopathic Thrombocytopenic Purpura 4.2%
Joint Dislocation 4.2%
Oral Pain 4.2%
Palpitations 4.2%
Panic Disorder 4.2%
Pyrexia 4.2%
Somnolence 4.2%
White Blood Cell Count Increased 4.2%
Abdominal Pain 2.1%
Arthritis Bacterial 2.1%
Contrast Media Reaction 2.1%
Dermatitis Exfoliative Generalised 2.1%
Concomitant
Hypertension 10.8%
Insomnia 9.6%
Rheumatoid Arthritis 7.9%
Prophylaxis 7.9%
Relapsing-remitting Multiple Sclerosis 7.6%
Pain 5.8%
Product Used For Unknown Indication 5.7%
Constipation 5.4%
Gastric Ulcer 5.3%
Drug Use For Unknown Indication 5.2%
Diabetes Mellitus 4.2%
Back Pain 4.2%
Depression 4.0%
Gastritis 3.6%
Spinal Osteoarthritis 2.6%
Anxiety 2.2%
Hyperlipidaemia 2.1%
Multiple Sclerosis 2.0%
Osteoporosis 1.9%
Parkinson's Disease 1.9%
White Blood Cell Count Increased 8.3%
Vomiting 7.7%
White Blood Cell Count Decreased 7.1%
Interstitial Lung Disease 5.9%
Palpitations 5.9%
Pyrexia 5.9%
Sleep Apnoea Syndrome 5.9%
Platelet Count Decreased 5.3%
Liver Disorder 4.7%
Urinary Retention 4.7%
Diffuse Large B-cell Lymphoma 4.1%
Drug Eruption 4.1%
Loss Of Consciousness 4.1%
Renal Impairment 4.1%
Somnolence 4.1%
Erythema Multiforme 3.6%
Hypoglycaemic Coma 3.6%
Neutrophil Count Decreased 3.6%
Respiratory Depression 3.6%
Rhabdomyolysis 3.6%